COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

03/11/2017 - 07:10

REGULATED INFORMATION GHENT, Belgium, 3 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

03/11/2017 - 07:05

pdf version of the press release This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

03/11/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 3 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

BAUSCH + LOMB ET NICOX ANNONCENT L'APPROBATION DE LA FDA POUR VYZULTA(TM) (SOLUTION OPHTALMIQUE DE LATANOPROSTÈNE BUNOD), 0,024%

02/11/2017 - 21:45

Contacts: Valeant Relations Investisseurs : Arthur Shannon arthur.shannon@valeant.com +1-514-856-3855 +1-877-281-6642 (toll free) Media: Lainie Keller lainie.keller@valeant.com +1-908-927-0617 Kristy Marks kristy.marks@ [...]

Novartis and Amgen announce expanded collaboration with Banner Alzheimer's Institute in pioneering prevention program

02/11/2017 - 21:30

Parties to collaborate on a new Generation Study 2, assessing whether investigational drug CNP520 can prevent or delay the symptoms of Alzheimer's disease (AD) Clinical trial is part of the Generation Program, which [...]

Medtronic Releases Fiscal Year 2017 Integrated Performance Report

02/11/2017 - 19:00

Report Highlights Company's Global Financial, Social, and Environmental Impact DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance Report. The report [...]

NICOX : Nombre de droits de vote au 31 octobre 2017

02/11/2017 - 17:45

Nicox SA Société anonyme au capital de 29 169 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 novembre 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]

NICOX : Number of voting rights as of October 31, 2017

02/11/2017 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,169,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On November 2, 2017, MONTHLY PUBLICATION OF THE [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

02/11/2017 - 17:44

Information relative au nombre total de droits de vote et d'actions composant le capital social 2 novembre 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

Composition of Terveystalo Plc Shareholders' Nomination Board

02/11/2017 - 17:20

Composition of Terveystalo Plc Shareholders' Nomination Board Terveystalo Plc Stock exchange release, 2 November 2017 at 6:20 p.m. Terveystalo's Nomination Board comprises the representatives of the five largest [...]

EastPharma Ltd Sales Update Announcement for the period 30 September 2017

02/11/2017 - 17:01

EASTPHARMA LTD. London, 2 November 2017 - EastPharma (EAST LI) announces that it is releasing its 9M 2017 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the [...]

Virbac : Déclaration d'actions et de droits de vote au 31 Octobre 2017

02/11/2017 - 16:14

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights as of October 2017, 31.

02/11/2017 - 16:14

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

LIDDS: New website and change of web address

02/11/2017 - 16:13

LIDDS has today launched a newly designed website that will better reflect the ongoing company activities and the NanoZolid ® project development pipeline. At the same time the web address is changed to www.liddspharma. [...]

Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy

02/11/2017 - 15:45

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with [...]

Sanofi et Alnylam présentent les résultats positifs complets de l'étude de phase 3 APOLLO consacrée à l'agent expérimental patisiran dans le traitement de l'amylose héréditaire à transthyrétine ave...

02/11/2017 - 15:45

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi et Alnylam présentent les résultats positifs complets de l'étude de phase 3 APOLLO consacrée à l'agent expérimental patisiran dans le traitement [...]

Solon Eiendom ASA : Invitation to presentation of third quarter 2017 results

02/11/2017 - 15:15

Oslo, 02 November 2017 - Solon Eiendom ASA will publish its third quarter 2017 results on Thursday 09 November at 06.30 am CET. The quarterly report and the presentation will be available on the company's web site, www. [...]

Solon Eiendom ASA : Invitasjon til presentasjon av 3.kvartal 2017

02/11/2017 - 15:15

Oslo, 02 November 2017 - Solon Eiendom ASA publiserer resultatet for 3.kvartal 2017 torsdag 09. november kl 06.30. Kvartalsrapporten og markedspresentasjon vil bli gjort tilgjengelig på selskapets hjemmeside, www. [...]

Medtronic Evolut(TM) PRO TAVR System with Advanced Sealing Maintains Excellent Outcomes Over Time

02/11/2017 - 15:00

Evolut PRO Valve Well-Positioned for Future with New Study Unveiled to Investigate Expanded Patient Population DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at the [...]